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Editorial on the Research Topic
Marine Microbial-Derived Molecules and Their Potential Medical and Cosmetic Applications
The marine environment is a vast, largely unexploited resource for acquiring a multitude
of microbial communities with a number of uncharacterized taxonomic groups and novel
biosynthetic capabilities. Marine habitats provide unique conditions for microbial growth and
secondary metabolite expressions that are not found in terrestrial ecosystems. The co-evolution
of many marine macroorganisms, especially invertebrates, with these microorganisms often leads
to a very close association or symbiotic relationship between the host organism and specific
microbial species driven by natural products. The ocean basin floor is covered in sediments of
different types and origins. Marine sediments are considered to be an incredibly rich source
of microbial taxonomic diversity, including “unculturable” microbes. “Unculturable” microbial
diversity presents a vast gene pool for biotechnological exploitation. In this context the secondary
metabolites produced by the microbial species and their biosynthetic pathways represent a resource
in the discovery of novel molecules or enzymes for a wide number of applications especially in the
medical and cosmetic field. Sustainable use of these resources is a methodological challenge for the
exploitation of “unculturable” microbes and their novel gene clusters responsible for biosynthetic
pathways for new bioactive compounds and enzymes. However, new culture techniques in addition
to culture-independent methods, such as PCR amplification from microbial community DNA
(metagenome) and functional or sequence-based screening of metagenomic DNA libraries are
proving useful. In recent years, efforts to characterize marine microbial metagenomics and their
associated compounds and enzymes have expanded significantly, but given the vastness of the
marine environment and the different types of microbial habitats found there, there is still room
for game-changing discoveries.
The scope of this Special Issue is to provide a broad and updated overview on marine
microbial community dynamics, genome sequencing and gene editing technology, marine
microbial-derived molecules, and their potential medical and cosmetic applications. The collection
includes 13 original research papers from prominent researchers in the field and provides the
readers of the journal with recent results in the area of microbial-derived molecules and their
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potential application in medical and cosmetic fields. Therefore,
this Special Issue promotes our understanding of marine-derived
biomolecules and their applications.
Emerging infectious diseases and multi-drug resistant human
pathogens are becoming a major threat to global health.
There is an urgent need for new antibiotics to fight evolving
bacterial infections, especially with respect to gram negative
pathogens. The marine habitat was shown to be a good source
for extremophiles, known to be potential resources for novel
bioactive metabolites. Gao et al. isolated 237 acidophilic/aciduric
fungi from Thai mangrove sediment in acidic medium,
and identified seven genera including Penicillium, Aspergillus,
Talaromyces, Cladosporium, Phoma, Alternaria, Trichoderma,
in four taxonomic orders of phylum Ascomycota. Ninety-
five percent of these isolates can grow under extremely
acidic conditions (pH 2). Many of them showed cytotoxic,
antimicrobial, anti-H1N1 activities. The metabolites obtained
from a typical aciduric fungus Pencillium oxalicum OUCMDZ-
5207 were identified as tetrahydroauroglaucin (1), flavoglaucin
(2), and auroglaucin (3), among which compound (3) showed
strong selective inhibition on A549 cells with IC50 5.67µM.
Cong et al. isolated 1,208 bacterial and fungus strains in 27
genera from Antarctica soil environments, and investigated their
physiology, enzyme activity and antifungal activity, respectively.
For example, four polyketones: versicone A (1), versicone B
(2), 4-methyl-5,6-dihydro-2H-pyran-2-one (3), and (R)-(+)-
sydowic acid (4), were found from Aspergillus sydowii strain
MS19. Compound (1) displayed strong activity against Candida
albicans, with a MIC value of 3.91µg/mL. Sarveswariv et al.
screened 42 Actinobacteria from a mangrove soil sample, and
found the biofilm inhibitory potential of Micromonospora sp.
RMA46 against Vibrio cholerae. They found that the ethyl
acetate extract of RMA46, mainly 2-methoxy-4-vinyl phenol
and hexahydro-3-(phenylmethyl)-pyrrolo [1,2-a] pyrazine-1,4-
dione, inhibited the formation of V. cholerae biofilms and
downregulated the quorum sensing global switches LuxO and
HapR. This study highlights Micromonospora sp. RMA46 as a
potential source of anti-infectives against V. cholerae.
The known peptide sublancin and a surfactin–like lipopeptide
demonstrate broad antimicrobial activity against Gram positive
bacteria and yeasts. Bacillus strains are well-known to produce
surfactins however Sharma et al. highlight the lipopeptide
synthesized by Bacillus subtilis strain A5 isolated from marine
sediment, as a candidate to inhibit Candida ssp. showing
synergistic action with fluconazole. The lipopeptide emulgel
formulation showed antimicrobial activity in vitro and no skin
irritation was observed in mice. Rehman et al. reported nine
sorbicillinoid derivatives (1–9), including six new compounds,
from a marine sponge-derived fungus Trichoderma reesei
(HN-2016-018). They discovered two novel sorbicillinoids
(1–2) with a characteristic naphthalene-trione ring and
two rare sorbicillinoids (3–4) possessing a bicycle (3.2.1)
lactone skeleton. Compound 3 represented the first reported
sorbicillinoid with a propan-2-one side chain. Compound
5 displayed strong cytotoxic activity against A549, MCF-7,
and HCT116 cell lines with the IC50 values of 5.1, 9.5, and
13.7µM, respectively. Paderog et al. reported about the isolation
of precursors of anti-cancer anthracycline shunt metabolites,
bisanhydoaklavinone and 1-hydroxybisanhydroaklavinone
from marine sediment-derived Streptomyces sp. strain DSD069
without genetic manipulation. These two substances have
antibiotic activity against S. aureus at MIC90 of 6.25 and
50µg/mL, respectively.
Chemical epigenetic or genetic manipulation has been widely
applied to microbes to obtain novel secondary metabolites or
enhance the production. Wu et al. investigated the marine
gorgonian-derived fungus Aspergillus versicolor XS-20090066
by chemical epigenetic manipulation with histone deacetylase
inhibitor and DNA methyltransferase inhibitor. The discovered
two new nucleoside derivatives, kipukasins K (1) and L (2),
and one new bisabolane sesquiterpene, aspergillusene E (7).
Compounds 1 and 7 exhibited antibacterial activities against
Staphylococcus epidermidis and S. aureus with the MIC values
of 8–16µg/mL. Compound 7 displayed potent anti-larval
attachment activity against bryozoan Bugula neritina with the
EC50 and LC50 values of 6.25 and 25µg/mL, respectively.
Yao et al. used gene knockout method and created a 1CtiS
mutant strain of from a marine-derived fungus Penicillium
steckii P2648 for biosynthesis of antibacterial compounds 1,
2, and 3 (isoquinoline alkaloids). Compounds 1 and 2 were
reported firstly from the natural resource in this study,
showed antibacterial activities against Staphylococcus aureus and
Enterococcus faecalis with the MIC values of 16–32µg/mL.
Atmosphere and room-temperature plasma (ARTP) mutagenesis
is an easy and fast method to generate the random mutational
library in different strains. Liu et al. used iterative ARTP
mutagenesis to obtainmutants from Streptomyces sp.MG010 and
achieved antibacterial activities significantly increased by 75%.
Most carrageenase degradation products are mixtures, which
makes it difficult to purify each type of oligosaccharide. Gui
et al. cloned and expressed the carrageenase gene Car3206
in Escherichia coli cells, based on the genome sequence of
an Antarctic Polaribacter sp. strain NJDZ03. The purified
recombinant Car3206 produces only disaccharides, which can
significantly reduce the cost of product purification in industrial
production. Chitosanase is a significant chitosan-degrading
enzyme forms chitooligosaccharides. Zheng et al. discovered
a new member of GH-46 chitosanase (CsnS) from deep-sea
bacterium Serratia sp. QD07. CsnS was a cold-adapted enzyme
with activity of 324 U/mL, and is favorable to the production of
(GlcN)2 and (GlcN)3, may have potential applications in the food
and pharmaceutical industries.
Alginate oligosaccharides (AOS) showed various biological
activities, with great potentials in industrial and biomedical
applications. Marine neoagaro-oligosaccharides (NAOS)
produced by most marine β-agarases always possess low DPs
(≤6) and limited categories. Qu et al. developed a novel
strategy, using truncated recombinant AgaM1 (trAgaM1), that
can efficiently produce NAOS especially with various DPs ≥8.
trAgaM1 producedNAOSwith various DPs (4–12), for examples,
neoagarodecaose (NA10), and neoagarododecaose (NA12) at
final concentrations of 3.02, and 3.02 g/L, respectively. Jin et al.
investigated AOS with varying degrees of polymerization (DP),
namely, AOS (DP2), AOS (DP4–6), and AOS (DP8–12), from
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a deep-sea agarolytic Flammeovirga pacifica strain WPAGA1.
They found that AOS could enhance hair growth after 30-days
treatment on the back skin of mice.
This Special Issue summarizes important findings related to
the marine microbial community, diverse bioactive materials,
and their potential applications. The issue provide new
possibilities for exploration and research on the novelties of
marine microbial natural products.
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